» Authors » Tom B Johannesen

Tom B Johannesen

Explore the profile of Tom B Johannesen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 1057
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Huang L, Jansen L, Verhoeven R, Ruurda J, Van Eycken L, De Schutter H, et al.
Ther Adv Med Oncol . 2021 Jul; 13:17588359211027837. PMID: 34262618
Aims: The role of resection remains debated in cases of metastatic gastric carcinoma (mGC). Some mGCs are technically resectable. At the population level, the real-world application of resection for mGC...
12.
Langseth O, Myklebust T, Johannesen T, Hjertner O, Waage A
Eur J Haematol . 2021 Jan; 106(4):529-536. PMID: 33455012
Objectives: In contrast to secondary primary malignancies (SPM) following multiple myeloma (MM), less is known about previous malignancies. We therefore conducted a population-based study to assess the patterns of previous...
13.
Brancher S, Stoer N, Weiderpass E, Damhuis R, Johannesen T, Botteri E, et al.
Br J Cancer . 2020 Dec; 124(5):1018-1025. PMID: 33262518
Background: We assessed associations between metformin use and survival in a nationwide Norwegian cohort of lung cancer (LC) patients. Methods: The study linked 22,324 LC patients from the Cancer Registry...
14.
Huang L, Jansen L, Balavarca Y, Verhoeven R, Ruurda J, Van Eycken L, et al.
Clin Transl Med . 2020 Nov; 10(6):e203. PMID: 33135354
Background: Resection is the cornerstone of curative treatment for many nonmetastatic gastric cancers (GCs), but the population treatment patterns remains largely unknown. This large international population-based study aimed at investigating...
15.
Groen J, Douwes T, van Eycken E, van der Geest L, Johannesen T, Besselink M, et al.
Ann Surg Oncol . 2020 May; 27(13):5337-5346. PMID: 32388741
Background: Elderly patients with pancreatic cancer are underrepresented in clinical trials, resulting in a lack of evidence. Objective: The aim of this study was to compare treatment and overall survival...
16.
Langseth O, Myklebust T, Johannesen T, Hjertner O, Waage A
Br J Haematol . 2020 May; 191(3):418-425. PMID: 32367512
Population-based studies from high-quality nationwide cancer registries provide an important alternative to clinical trials in the assessment of the impact of modern myeloma treatment. Based on data from the Cancer...
17.
Rostgaard K, Hjalgrim H, Madanat-Harjuoja L, Johannesen T, Collin S, Hjalgrim L
Br J Cancer . 2019 Nov; 121(12):1079-1084. PMID: 31719686
Background: The present study aimed to assess whether the widespread concern of inferior cancer survival in adolescents and young adults (AYAs) compared with children and adults holds true in a...
18.
Hjelle K, Johannesen T, Bostad L, Reisaeter L, Beisland C
Eur Urol Oncol . 2019 May; 1(3):252-261. PMID: 31102628
Background: Guidelines on surgical treatment for kidney cancer (KC) have changed over the last 10 yr. We present population-based data for patients with KC tumors ≤7cm from 2008 to 2013...
19.
Huang L, Balavarca Y, van der Geest L, Lemmens V, Van Eycken L, De Schutter H, et al.
BMC Med . 2019 Mar; 17(1):66. PMID: 30905320
Background: Pancreatic cancer (PaC) remains extremely lethal worldwide even after resection. PaC resection rates are low, making prognostic studies in resected PaC difficult. This large international population-based study aimed at...
20.
Jonsson V, Awan H, Jones N, Johannesen T, Steig B, Andosdottir G, et al.
Sci Rep . 2019 Feb; 9(1):2444. PMID: 30792429
Malignant blood disorders depend on heritable susceptibility genes and occur in familial aggregations. We suggest a model of transgenerational segregation of the susceptibility genes based on the study of malignant...